Identification and detection of the common 65-kb deletion breakpoint in the nephropathic cystinosis gene (CTNS)

被引:64
作者
Anikster, Y [1 ]
Lucero, C
Touchman, JW
Huizing, M
McDowell, G
Shotelersuk, V
Green, ED
Gahl, WA
机构
[1] NICHHD, Sect Human Biochem Genet, Heritable Disorders Branch, NIH, Bethesda, MD 20892 USA
[2] Natl Human Genome Res Inst, Med Genet Branch, NIH, Bethesda, MD 20892 USA
[3] Natl Human Genome Res Inst, Genome Technol Branch, NIH, Bethesda, MD 20892 USA
[4] NIH, Intramural Sequencing Ctr, Gaithersburg, MD 20877 USA
关键词
cystinosis; deletion; multiplex PCR; sample sequencing; founder effect;
D O I
10.1006/mgme.1998.2790
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The most common mutation in the cystinosis gene, CTNS, is a 65-kb deletion thought to have originated in Germany. Although homozygotes for this deletion are detectable by the absence of the D17S829 polymorphic marker, no method exists to identify heterozygotes. We identified the 65-kb deletion breakpoints and used flanking PCR primers to amplify a 423-bp fragment present only in the deletion alleles. Using this method, we determined that 121 of 216 (56%) cystinosis alleles examined bore the 65-kb deletion. We found no non-Europeans with the deletion, and the deletion size and breakpoints appeared identical in all patients studied, supporting the concept of a founder effect. The addition of D17S829 primers (266 bp apart) to the PCR created a multiplex PCR system useful for diagnosing cystinosis patients homozygous and heterozygous for the 65-kb deletion.
引用
收藏
页码:111 / 116
页数:6
相关论文
共 32 条
  • [1] DISTAL VACUOLAR MYOPATHY IN NEPHROPATHIC CYSTINOSIS
    CHARNAS, LR
    LUCIANO, CA
    DALAKAS, M
    GILLIATT, RW
    BERNARDINI, I
    ISHAK, K
    CWIK, VA
    FRAKER, D
    BRUSHART, TA
    GAHL, WA
    [J]. ANNALS OF NEUROLOGY, 1994, 35 (02) : 181 - 188
  • [2] PITUITARY-TESTICULAR FUNCTION IN NEPHROPATHIC CYSTINOSIS
    CHIK, CL
    FRIEDMAN, A
    MERRIAM, GR
    GAHL, WA
    [J]. ANNALS OF INTERNAL MEDICINE, 1993, 119 (07) : 568 - 575
  • [3] EVIDENCE FOR CEREBRAL INVOLVEMENT IN NEPHROPATHIC CYSTINOSIS
    EHRICH, JHH
    STOEPPLER, L
    OFFNER, G
    BRODEHL, J
    [J]. NEUROPADIATRIE, 1979, 10 (02): : 128 - 137
  • [4] NEUROLOGIC COMPLICATIONS IN LONG-STANDING NEPHROPATHIC CYSTINOSIS
    FINK, JK
    BROUWERS, P
    BARTON, N
    MALEKZADEH, MH
    SATO, S
    HILL, S
    COHEN, WE
    FIVUSH, B
    GAHL, WA
    [J]. ARCHIVES OF NEUROLOGY, 1989, 46 (05) : 543 - 548
  • [5] PANCREATIC EXOCRINE INSUFFICIENCY IN A PATIENT WITH NEPHROPATHIC CYSTINOSIS
    FIVUSH, B
    FLICK, JA
    GAHL, WA
    [J]. JOURNAL OF PEDIATRICS, 1988, 112 (01) : 49 - 51
  • [6] PANCREATIC ENDOCRINE INSUFFICIENCY IN POSTTRANSPLANT CYSTINOSIS
    FIVUSH, B
    GREEN, OC
    PORTER, CC
    BALFE, JW
    OREGAN, S
    GAHL, WA
    [J]. AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1987, 141 (10): : 1087 - 1089
  • [7] Gahl W A, 1986, Adv Pediatr, V33, P95
  • [8] CYSTEAMINE DEPLETES CYSTINOTIC LEUKOCYTE GRANULAR FRACTIONS OF CYSTINE BY THE MECHANISM OF DISULFIDE INTERCHANGE
    GAHL, WA
    TIETZE, F
    BUTLER, JD
    SCHULMAN, JD
    [J]. BIOCHEMICAL JOURNAL, 1985, 228 (03) : 545 - 550
  • [9] CYSTEAMINE THERAPY FOR CHILDREN WITH NEPHROPATHIC CYSTINOSIS
    GAHL, WA
    REED, GF
    THOENE, JG
    SCHULMAN, JD
    RIZZO, WB
    JONAS, AJ
    DENMAN, DW
    SCHLESSELMAN, JJ
    CORDEN, BJ
    SCHNEIDER, JA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (16) : 971 - 977
  • [10] GAHL WA, 1982, J BIOL CHEM, V257, P9570